Skip to main content

Advertisement

Table 4 Univariable and multivariable analyses for each clinical feature

From: Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer

Clinical featureNumberUnivariate analysisMultivariate analysis
HR95%CI of HRP valueHR95%CI of HRP value
Risk parameter
(High-risk/Low-risk)
274/2743.5292.186–5.699< 0.0012.4821.832–4.2580.038
Age (≥ 66/< 66)236/3101.8171.180–2.7980.0071.4820.820–2.6780.192
Stage (I/II–IV)341/2073.5772.288–5.594< 0.0011.6581.010–2.7210.046
Grade (G1/G2–3)99/43812.8113.148–52.128< 0.0017.8261.052–58.2050.044
Residual tumor (yes/no)22/3762.8841.778–4.678< 0.0010.7450.402–1.3800.349
New tumor event (yes/no)63/4854.9313.189–7.625< 0.0012.7731.604–4.798< 0.001
Neoplasm cancer status
(with tumor/tumor free)
79/4316.4044.140–9.908< 0.0013.5091.895–6.498< 0.001
Histological type (endometrioid adenocarcinoma/others)411/1371.8541.186–2.8960.0070.7080.406–1.2370.225